The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.

With a 95% retention rate for nurse residents completing the program and a 100% 2-year post-hire retention rate, these initiatives ensure a stable and well-trained workforce.

A team of researchers explain how navigation programs work, who benefits, and how to create a successful navigation program.

Researchers sought to determine whether a pharmacist-led clinic for administering venetoclax would be effective for patients with CLL.

Prior screening mammography linked to earlier stage at breast cancer diagnosis, lower breast cancer mortality.

Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

The Fatigue Scale provides a reliable measure of fatigue in most populations of pediatric patients with cancer.

Researchers describe how they developed a program for home-based management of indwelling PICC to improve patient self-management.

The rising trajectory in the inability to pay for health care is a disturbing trend that is likely to continue and even accelerate,” said Tim Lash.

Current guidelines do not specify the ideal timing between standard TURBT, neoadjuvant chemotherapy, and radical cystectomy in patients with muscle-invasive bladder cancer.